Drug Side Effects
Search
CONGENITAL OSTEODYSTROPHY
CONGENITAL OSTEODYSTROPHY
was reported 39 times
CONGENITAL OSTEODYSTROPHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
7
0.0005
1
Recombinant Human Growth Hormone [EPC]
2
0.0001
2
Prostaglandin E1 Analog [EPC]
1
0.0001
3
Vitamin D3 Analog [EPC]
1
0.0000
4
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
5
Leukotriene Receptor Antagonist [EPC]
1
0.0000
6
Protease Inhibitor [EPC]
1
0.0000
7
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
8
Cytochrome P450 3A Inhibitor [EPC]
1
0.0000
9
Antidote [EPC]
1
0.0000
10
Platinum-based Drug [EPC]
4
0.0000
11
Tetracycline-class Drug [EPC]
1
0.0000
12
Proton Pump Inhibitor [EPC]
8
0.0000
13
Mood Stabilizer [EPC]
3
0.0000
14
Alkylating Drug [EPC]
3
0.0000
15
Dietary Cholesterol Absorption Inhibitor [EPC]
1
0.0000
16
Purine Antimetabolite [EPC]
1
0.0000
17
Anti-epileptic Agent [EPC]
2
0.0000
18
Sulfonylurea [EPC]
1
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
20
Calcium [EPC]
1
0.0000
21
Platelet Aggregation Inhibitor [EPC]
2
0.0000
22
Nonsteroidal Anti-inflammatory Drug [EPC]
4
0.0000
23
Atypical Antipsychotic [EPC]
1
0.0000